Stock Market Watch

HEB Update and Free Stock Report

by ·


This is how we do it!

  • James Settle: HEB ,OUT for $3,475 profit ,,,ty gang
  • Tiger .: k took my profit on HEB $1,050 aprox thank you
  • Shradmoney .: Great call on HEB SA! $960 profit here.
  • Tali D: out of HEB in at .76 out @ .90 250000 shares $20,000 plus profits
  • Jeff, Just want to let you know we followed your advice on HEB yesterday – securing 500000 shares in pieces at between .75 -.81. will sell at the bell in pieces as well. Thanks for keeping us on top of the trades. We expect between $65K to $85 K profit. Our clients love your service ~ Jim

So you want a free report on my next trade and a little breakdown?

Start the video below and then set the player to 720p HD or 1080p HD and then fullscreen mode.

Now, this week we have seen PSID +40%, CBIS +40%, HEB +15% STEM +13% URRE -2% and AONE -5%. Add that up and its possible 100% plus vs. 7% down.

If you are serious about making money off these scalps and, for a full report on other hot moving penny and small cap stocks please click here.

Stop hanging out with the other penny stock pump newsletters and join us now by clicking here. We offer memberships now to TWO great newsletters in SuperNova Elite and now Options Elite. Join SuperNova Now / Join Options Elite Now

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Its products include Ampligen, an experimental drug under clinical development for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Hepatitis B, human immunodeficiency virus (HIV), renal cell carcinoma, and malignant melanoma; Alferon N Injection, an injectable formulation of natural alpha interferon for the treatment of certain categories of genital warts; and Alferon LDO, an experimental low-dose oral liquid formulation of natural alpha interferon for the treatment of influenza and other emerging viral diseases. The company outsources certain components of its research and development, manufacturing, marketing, and distribution operations to third-parties.

Yingli Green Energy Holding Company Limited, together with its subsidiaries, engages in the design, development, manufacture, assembling, sale, and installation of photovoltaic (PV) products in the People’s Republic of China and internationally. The company offers PV cells, PV modules, and integrated PV systems, as well as polysilicon ingots, blocks, and wafers. Yingli Green Energy Holding Company Limited primarily sells its PV modules to distributors, wholesalers, power plant developers and operators, and PV system integrators in Germany, the United States, Italy, China, Spain, the Netherlands, France, the United Kingdom, Japan, Israel, and Slovenia under Yingli and Yingli Solar brand names. The company also sells its products to end-users through sales representatives.

More Posts by this author

Jeff Williams (Top Stock Picks)
Post Written By: Jeff Williams
My name is Jeff Williams of TopStockPicks.com. As a trader, I have spent the last 15 years navigating and scanning the penny stock markets. I don’t know anyone who has the breadth and depth of penny stock experience that I do. Through my proven methods I have consistently found some of the markets biggest and most profitable trades…and the great news is that I will share them with all of my subscribers. Signup for my newsletter at TopStockPicks.com

Tags:

Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing.

You may also like...